Mitochondria are central organelles for cellular metabolism. In cancer cells, mitochondrial oxidative phosphorylation (OXPHOS) dysfunction has been shown to promote migration, invasion, metastization and apoptosis resistance. With the purpose of analysing the effects of OXPHOS dysfunction in cancer cells and the molecular players involved, we generated cybrid cell lines harbouring either wild-type (WT) or mutant mitochondrial DNA (mtDNA) [tRNAmut cybrids, which harbour the pathogenic A3243T mutation in the leucine transfer RNA gene (tRNAleu)]. tRNAmut cybrids exhibited lower oxygen consumption and higher glucose consumption and lactate production than WT cybrids. tRNAmut cybrids displayed increased motility and migration capacities, which were associated with altered integrin-β1 N-glycosylation, in particular with higher levels of β-1,6-N-acetylglucosamine (GlcNAc) branched N-glycans. This integrin-β1 N-glycosylation pattern was correlated with higher levels of membrane-bound integrin-β1 and also with increased binding to fibronectin. When cultured in vitro, tRNAmut cybrids presented lower growth rate than WT cybrids, however, when injected in nude mice, tRNAmut cybrids produced larger tumours and showed higher metastatic potential than WT cybrids. We conclude that mtDNA-driven OXPHOS dysfunction correlates with increased motility and migration capacities, through a mechanism that may involve the cross talk between cancer cell mitochondria and the extracellular matrix.
Introduction
Metabolic re-wiring, or the ability to adapt cellular metabolism to growth, migration and invasion, has gained considerable attention in the cancer research field over the past decade. A cancer, by definition a proliferating and ultimately invading and metastasizing cell mass, has different nutritional demands than those of most adult tissues, which are mainly in a quiescent state (1) . A key feature of the metabolic re-wiring of cancer cells is the high rate of glucose uptake to meet their increased energetic and biosynthetic needs and produce a full-blown tumour (2) . Cancer cells often display the so-called 'Warburg effect', i.e. they convert most of the glucose to lactate, rather than metabolizing it through mitochondrial oxidative phosphorylation (OXPHOS), even in the presence of oxygen (3, 4) . This phenomenon sets mitochondrial activity, in particular OXPHOS, as a central metabolic function for tumour cells. In fact, OXPHOS activity in tumour cells is still controversial, as there are arguments supporting a deficient OX-PHOS in tumourigenesis, and others agreeing with an effective utilization of OXPHOS by tumour cells (5) . An increasingly accepted notion is that multiple types of tumour bioenergetic signatures occur, ranging from mainly oxidative to exclusively glycolytic, in which OXPHOS activity is significantly reduced (6) .
Several mechanisms are able to induce OXPHOS downregulation in cancer, including those associated with the microenvironment (low oxygen tension) and oncogenic pathway activation [where hypoxia inducible factor-1alpha (HIF-1α) appears as a key molecule], as well as those related to genetic alterations in OXPHOS-related genes encoded by the nuclear DNA or mitochondrial DNA (mtDNA). mtDNA mutations have been detected in a wide variety of human tumours and, in some instances, associated with poor prognosis (7) (8) (9) . Such mutations are often deleterious and result in OXPHOS impairment, thereby altering mitochondrial bioenergetics and biosynthesis (10) . There is compelling evidence that mtDNA mutations not only lead to OXPHOS deficiency, but also empower cancer cells with enhanced tumourigenic properties, namely increased capacity to migrate, invade and metastasize (11, 12) . Nonetheless, there is scant information about the molecular mechanisms and signalling pathways that connect mtDNA mutations/OXPHOS deficiency with migration, invasion and metastization. In the process of migration and invasion, cancer cells bind to molecules of the extracellular matrix (ECM) through the integrin family of transmembrane glycoprotein receptors (13) . Integrins are heterodimers composed of α and β subunits and mediate anchorage and migration of cancer cells over a variety of ECM molecules, such as collagen, fibronectin, laminin and vitronectin (13) .
In this study, we have generated cybrid cancer cell lines that recapitulate the setting of OXPHOS deficiency (caused by a mtDNA tRNAleu mutation) and normal OXPHOS [with wild-type (WT) mtDNA]. In comparison with control cells, OXPHOS-deficient cells displayed increased motility and migration properties, which were associated with differential glycosylation and membrane localization of integrin-β1, together with increased expression of fibronectin.
Results

Generation of cybrid cell lines
Cybrid (cytoplasmic hybrid) cell lines are hybrid cells where the nuclear and mitochondrial genomes are from different sources (14) . Cybrids are a valuable in vitro cellular system for the study of mitochondrial gene function, because they allow the comparison of different mtDNA genomes (either WT or mutant) against the same nuclear background.
To create cybrids with OXPHOS dysfunction (hereafter named tRNAmut cybrids), we fused mtDNA-depleted cells (143Bρ0 cells), which were derived from the osteosarcoma cell line 143B, with platelets harbouring the mtDNA A3243T mutation in the tRNAleu (UUR) gene, previously described as pathogenic (15) . The platelets were obtained from a patient who was diagnosed with encephalomyopathy and harboured the aforementioned mutation. As controls, we used cybrids that were generated from the fusion of 143Bρ0 cells with WT mtDNA platelets, obtained from a healthy blood donor (hereafter named WT cybrids). The restoration of the expression of the mtDNA-encoded protein cytochrome c oxidase II (COXII) confirms that both WT and tRNAmut cybrids were successfully generated (Fig. 1A) . On the other hand, 143Bρo cells, which lack mtDNA, do not express COXII (Fig. 1A) , but do show expression of the nuclear-encoded mitochondrial protein succinate dehydrogenase subunit A (SDHA) (Fig. 1B) .
As each cell has multiple mtDNA copies, we sequenced the mtDNA to analyse the proportion of mtDNA-mutant molecules, also designated as the degree of heteroplasmy. We determined that tRNAmut cybrids display the A3243T mutation in ∼50% of mtDNA molecules (Fig. 1C) .
Complete mtDNA sequencing of the 143B cell line and the two cybrids confirmed the absence of mtDNA mutations in 143B and WT cybrids and that the tRNAmut cybrids only harbour the A3243T mutation in the tRNAleu (UUR) (data not shown).
tRNAmut cybrids display decreased oxygen consumption and increased glycolytic rate than WT cybrids After generating the WT and tRNAmut cybrids, we evaluated the metabolic changes induced by the mtDNA mutation, namely at the level of oxygen consumption (as a measure of OXPHOS function), as well as glucose consumption and lactate production (as a measure of glycolysis). As expected, 143Bρo cells showed almost no oxygen consumption, while tRNAmut cybrids presented a significant decrease in basal oxygen consumption when compared with WT cybrids ( Fig. 2A) , confirming that the tRNA mutation leads to decreased OXPHOS function. Treatment with the complex V inhibitor oligomycin significantly decreased oxygen consumption in 143B and WT cybrids, but had no effect in 143Bρ0 (Fig. 2B) . tRNAmut cybrids were less sensitive to oligomycin, indicating that these cells might have complex V impairment (Fig. 2B ). The treatment with carbonyl cyanide 3 chlorophenylhydrazone (CCCP), which forces the mitochondria to work at its maximum respiratory capacity, increased oxygen consumption in 143B, WT cybrids and tRNAmut cybrids but not in 143Bρ0 (Fig. 2B) .
The aforementioned differences in oxygen consumption were mirrored by the glycolytic rate of the cell lines. Glucose and lactate levels were quantified in the medium at 0 h and after 96 h of cell culture. Glucose consumption was significantly increased in 143Bρ0 and tRNAmut cybrids when compared with 143B and WT cybrids, respectively (Fig. 3A) . Additionally, we observed that 143Bρ0 and tRNAmut cybrids produced more lactate when compared with 143B and WT cybrids, respectively (Fig. 3B) .
The combined results of oxygen consumption, glucose consumption and lactate production suggest that the mtDNA tRNA mutation leads to OXPHOS dysfunction and a concomitant increase in glycolytic rate, a phenotype that recapitulates the Warburg effect.
It has been shown that there is a threshold for the positive tumourigenic effects of mtDNA mutations; above this threshold, there is energetic impairment that prevents tumour growth (16) . We thus decided to focus our analysis in the tumourigenic effects of OXPHOS dysfunction using the tRNAmut cybrids that present 50% of mutation load and compare them with 143B and WT cybrids that have normal mtDNA. Considering that complete lack of mtDNA does not occur in human tumours, 143Bρ0 cells were not further analysed.
Cellular growth and apoptosis are decreased in tRNAmut cybrids
To address the consequences of OXPHOS dysfunction at the level of cellular growth, we counted cells over a period of 5 days and observed that tRNAmut cybrids had significantly lower growth rates than WT cybrids and 143B cells (Fig. 4A ). This result indicates that, under optimal growth conditions, cells with OXPHOS deficiency have a decreased growth capacity in comparison with cells with normal OXPHOS.
Apoptosis was evaluated in the cybrid cell lines after treatment with 50 n staurosporine (STS) [the concentration that most reflected the differences between cell lines (data not shown)]. By determining the geometric mean of the histogram, we confirmed that STS induced apoptosis in all cell lines, although this effect was only statistically significant in 143B (2-fold increase compared with untreated cells). WT cybrids showed a 1.7-fold increase compared with untreated cells, while tRNAmut cybrids were the least sensitive to STS (1.15-fold increase compared with untreated cells) ( Fig. 4B and C) .
Motility and migration are increased in tRNAmut cybrids
Upon observation of the cell lines under bright field microscopy, there were evident morphological differences between the cell lines: tRNAmut cybrids presented a more spindle-like phenotype and reduced cell-cell contacts, when compared with 143B and WT cybrids (Fig. 5) .
Because such morphological differences can denote different cellular migration and motility capabilities, we assessed the distance covered by single cells in the plate (motility) and the rate of closure over time in the wound-healing assay (migration) of the three cell lines, using time-lapse microscopy. In a 14 h period, tRNAmut cybrids showed significantly more individual cell motility than 143B and WT cybrids: tRNAmut cells, on average, covered ∼3.3 times the distance of 143B and WT cybrids ( Fig. 6A  and B ). In addition, the wound-healing assay showed that tRNAmut cells had the highest migratory capacity, covering 87% of the wound in 8 h, comparing with WT cybrids (43% of wound coverage) and 143B (35% of wound coverage) ( Fig. 6C and D) .
tRNAmut cybrids display increased expression and binding to fibronectin A fundamental step in cancer cell motility and migration is the interaction with the surrounding stroma. Cancer cells often secrete ECM proteins and reshape the surface expression of cell-matrix interacting molecules, such as integrins, to promote their capacity to migrate and invade the adjacent tissues (17). To test the binding capacity to different ECM substrates, we performed an adhesion assay by culturing cells in wells coated with collagen type I, collagen type IV, fibronectin or poly-lysine (positive control). We observed that tRNAmut cybrids adhered more efficiently to fibronectin than 143B and WT cybrids (Fig. 7A) , while the binding to collagen type I or IV was not significantly altered ( Fig. 7B and C, respectively) . Furthermore, in western-blot (WB) analysis, tRNAmut cells showed significantly increased levels of fibronectin when compared with WT cybrids and 143B ( Fig. 8A and B) .
tRNAmut cybrids display increased modification of integrin-β1 with β-1,6 GlcNAc branched N-glycans structures Considering that tRNAmut cybrids show higher motility, migration and binding capacity to fibronectin than 143B and WT cybrids, we addressed the status of integrin-β1 in the three cell lines. Integrins are known to play a crucial role in adhesion to the ECM, thereby contributing to migration, invasion and metastization of tumour cells (18) . Integrin-β1 is one of the major players in these processes and is known to preferentially bind to fibronectin after dimerization with integrin-α5 (19) .
In the WB analysis, integrin-β1 showed two distinct bands: an upper band with ∼130 kDa and a lower band of ∼115 kDa (Fig. 8A) . Although the overall expression of integrin-β1 did not differ between the three cell lines (Fig. 8C ), there was a clear difference in the relative intensity of the upper and lower band: while the parental 143B displayed similar intensity of both bands, the WT cybrids have more expression of 115 kDa integrin-β1 and tRNAmut cybrids were enriched in the 130 kDa band (Fig. 8D) . In addition, the integrin-β1 130 kDa band of tRNAmut cybrids also showed less mobility in the gel than the same band of 143B and WT cybrids (Fig. 8A ). glucose consumption and lactate production were significantly elevated in 143Bρ0 and tRNAmut cybrids when compared with 143B and WT cybrids, respectively. Results are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001. Results are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001. Glycosylation modifications have been described to be a key regulatory mechanism of several cell biology processes, including cell adhesion and cell-matrix interaction, particularly affecting the integrin-mediated cellular migration (20, 21) . Taking into account that integrin-β1 is modified by N-glycosylation and that glycosylation affects the protein mobility in sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gels, we characterized the integrin-β1 N-glycosylation profile in each cybrid cancer cell lines using two different N-glycosidases: endoglycosidase H (Endo H), which is an endoglycosidase that cleaves within the chitobiose core of high mannose and some hybrid oligosaccharides from N-linked glycoproteins, and peptide-N-glycosidase F (PNGase F), which is an amidase that cleaves between the innermost GlcNAc and asparagine residues of high mannose, hybrid and complex oligosaccharides from N-linked glycoproteins. In 143B and WT cybrids, Endo H digestion completely converted the 115 kDa band to an 85 kDa band (corresponding to the size of integrin-β1 core protein), while in tRNAmut cybrids, Endo H only yielded a faint digestion product (Fig. 9A ). On the other hand, PNGase F digestion converted the 130 and 115 kDa bands to the 85 kDa-sized integrin-β1 in 143B, WT cybrids and tRNAmut cybrids (Fig. 9A ). These results indicate that, in 143B and WT cells, integrin-β1 is modified with high mannose, hybrid and complex type N-glycans, whereas in tRNAmut cybrids, integrin-β1 is mainly modified with complex type N-glycans. To determine whether integrin-β1 from tRNAmut cells are modified with the β-1,6 GlcNAc branched structures catalysed by beta1,6 N-acetylglucosaminyltransferase V (GnT-V) enzyme, we performed integrin-β1 immunoprecipitation followed by β-1,6 GlcNAc branched N-glycans recognition using the phaseolus vulgaris leucoagglutinin lectin (L-PHA). The increased L-PHA reactivity in tRNAmut cybrids, in comparison with 143B and WT Figure 5 . Light microscopy images of 143B (A), WT cybrids (B) and tRNAmut cybrids (C). The tRNAmut cybrids display reduced cell-cell contacts, showing a more spindle-like morphology than 143B and WT cybrids. Pictures were taken using the 20× objective. Figure 6 . Time-lapse microscopy was used to evaluate motility (distance covered by single cells in a 14 h period; A and B) and migration (wound-healing assay in a 14 h period; C and D). In (A), the lines show the distance covered by single cells. In (C) the top panel represents the wound at baseline and the bottom panel represents the wound after 14hrs. tRNAmut cybrids showed significantly increased motility and migration when compared with 143B and WT cybrids. Each image is representative of three independent experiments. Results are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001.
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tRNAmut cybrids show predominantly integrin-β1 and integrin-α5β1 membrane localization
We next assessed whether the differences in integrin-β1 glycosylation had an impact on its sub-cellular localization, as it had been previously shown (22) . Using immunofluorescence staining, tRNAmut cybrids showed predominantly membrane-localized integrin-β1, in structures that resembled focal adhesions (Fig. 10A, upper-right picture) . On the other hand, 143B and WT cybrids (Fig. 10A , upper-left and upper-middle pictures, respectively) showed mostly cytoplasmic staining. To quantify the levels of membrane-bound integrin-β1, we have used imaging flow cytometry that enables the quantification of proteins in different cellular compartments. Applying a setting that specifically quantifies the levels of membrane-localized integrin-β1, we saw that the tRNAmut cybrids displayed higher levels of membrane-bound integrin-β1 than 143B and WT cybrids (Fig. 11A) . In addition, after categorizing the expression levels of membrane-bound integrin-β1 as low or high (Fig. 11E) , we observed that, in the tRNAmut cybrids, the percentage of cells displaying strong expression of membrane-bound integrin-β1 was increased in comparison with 143B or WT cybrids (Fig. 11B) . Conversely, 143B or WT cybrids had a higher percentage of cells displaying low expression of membrane-bound integrin-β1 than tRNAmut cybrids (Fig. 11B) .
Because integrin-β1 requires dimerization with α subunits for proper function, we have used the same imaging flow cytometry analysis to quantify the levels of membrane-bound integrin-α5β1, the dimer that preferentially binds fibronectin. Similarly to what we observed for integrin-β1, the levels of membranebound integrin-α5β1 were elevated in tRNAmut cybrids, when compared with 143B and WT cybrids (Fig. 11C) . tRNAmut cybrids also showed a higher percentage of cells with a higher expression of membrane-bound integrin-α5β1 and lower percentage of cells with low expression, when compared with 143B and WT cybrids (Fig. 11D ).
Phenformin, a complex I inhibitor, mimics the effects of the tRNA mutation Phenformin is a selective OXPHOS complex I inhibitor (23) . We have tested the effects of phenformin in WT cybrids and found that it inhibited O 2 consumption to a degree similar to that of oligomycin (Fig. 10C) . To evaluate whether phenformin-induced OXPHOS dysfunction in 143B and WT cybrids had an impact on integrin-β1 localization, we treated cells with 5 m of phenformin for 1 h and evaluated the effects by confocal microscopy and imaging flow cytometry. Using tRNAmut cybrids adhere more efficiently to fibronectin than 143B or WT cybrids, while no differences were observed concerning collagen type I or type IV. Results are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001. are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001. confocal microscopy, 143B and WT cybrids showed membrane re-localization of integrin-β1 with a pattern that closely resembled that of tRNAmut cybrids, whereas phenformin had little effect on integrin-β1 localization in tRNAmut cybrids (Fig. 10A, bottom panels) . After quantification by imaging flow cytometry, we confirmed that phenformin increased the levels of membrane-localized integrin-β1 in all cell lines, although only reaching the level of statistical significance in WT cybrids (Fig. 10B) . Such effect was less evident in the tRNAmut cybrids that intrinsically have OXPHOS dysfunction and present higher levels of membrane-bound integrin-β1 (Fig. 10B ).
tRNAmut cybrids have higher tumourigenic potential in nude mice than WT cybrids
Taking into consideration that a metabolic defect might have considerably different effects depending on the microenvironment, we assessed the tumour-forming capacity of WT and tRNAmut cybrids in vivo. One million cells were injected in the Results are representative of at least three independent experiments; error bars are SEM; *P < 0.05; **P < 0.01; ***P < 0.001.
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dorsal flank of nude mice and tumour growth was monitored for ∼36 days. While tumour formation was observed in all mice injected either with WT or with tRNAmut cybrid cells (except one mouse injected with the WT cybrid), the tumours derived from tRNAmut cybrids were significantly larger in volume than tumours derived from WT cybrids (Fig. 12A) . In addition, we observed metastatic foci in the lungs of 3 of the 14 mice injected with tRNAmut cybrids, while no animal injected with WT cybrids had lung metastases (data not shown). To further assess the metastatic potential of WT and tRNAmut cybrids, we repeated the in vivo tumour-forming capacity experiment, but instead of sacrificing the animals by Day 36, the tumours were removed and the mice were kept alive until Day 49 (13 days after tumour removal) to allow the formation of metastases. After collecting the lungs of the animals, we performed immunohistochemistry against vimentin (a marker expressed by WT and tRNAmut cybrids) and found that 67% of mice injected with tRNAmut cybrids displayed lung metastases, whereas only 33% of mice injected with WT cybrids had lung metastases (Fig. 12B and C) .
Discussion
In his seminal works, Warburg postulated that deficient OXPHOS was on the origin of tumourigenesis, owing to his consistent observations of lack of respiration and increased lactate production in human tumours (3) . Because this phenotype persisted even in the presence of oxygen, Warburg designated it as aerobic glycolysis. Several lines of evidence have confirmed that OXPHOS deficiency is common to many human tumours, although its functional role in tumour development remains under study.
The consequences of mitochondrial OXPHOS dysfunction in cancer cells have been addressed by various approaches, namely chemical inhibition (using OXPHOS-targeted drugs, such as oligomycin, rotenone or phenformin) or genetic manipulation, via the introduction of mtDNA mutations (cybrid cell lines). mtDNA mutations are found in a wide variety of cancers, such as colorectal, thyroid, gastric, breast, leukaemia, glioblastoma and prostate (10, (24) (25) (26) (27) (28) . Many of such mutations are deleterious and able to inhibit OXPHOS, implying that alterations in mitochondrial bioenergetics and metabolism have a role in supporting neoplastic transformation. An interesting finding is that there is no mutational hotspot within mtDNA; instead, mtDNA mutations are scattered across the mitochondrial genome, spanning all the OX-PHOS-encoding genes, suggesting that the key target is OXPHOS function, rather than a specific gene.
Following the genetic-based strategy, we created a cybrid cell model, where we engineered cells to have WT mtDNA (WT cybrids) or a pathogenic mtDNA mutation (tRNAmut cybrids). Given the diversity of mtDNA mutations found in human cancers, we chose to use a deleterious mutation (A3243T in the leucine tRNA) that clearly induces OXPHOS dysfunction (15) . In this way, our model is well fitted to address the converging outcome of mtDNA mutations, i.e. OXPHOS dysfunction. In addition, this mutation occurs in the same nucleotide as the A3243G, which has already been detected in human cancers (29, 30) . Our results showed that tRNAmut cybrids exhibited OXPHOS dysfunction, because they display lower oxygen consumption when compared with WT cybrids. This is in line with a previous report showing that the same germline mutation caused decreased activity of complexes I, III and IV in the muscle fibres of an encephalomyopathy patient (15) . Furthermore, tRNAmut cybrids showed a metabolic shift towards aerobic glycolysis, as evidenced by the increased glucose consumption and lactate production. This cybrid model thus constitutes a valuable tool to study the phenotypic effects of OXPHOS dysfunction.
The influence of the microenvironment over tumour cell behaviour is an important aspect for studying the relevance of altered metabolism in tumourigenesis. When we compared growth capacity in vitro, tRNAmut cybrids showed slower growth rate than WT cybrids. However, when injected in the dorsal flank of nude mice, tRNAmut cybrids produced larger and fastergrowing tumours. These results are in accordance with previous studies using cybrid cells (31) (32) (33) and fit with numerous examples where the in vivo results diverge from the results obtained in vitro. It is possible that, within the microenvironment where the cells are injected, the nutrient availability, presence of fibroblasts and immune cells may provide growth advantage to OXPHOSdeficient cells, while optimal in vitro growth conditions benefit OXPHOS-proficient cells. Moreover, tRNAmut cybrids seem to be more resistant to the apoptosis inducer STS, a finding that could also explain the increased size of the tumours produced by tRNAmut cybrids in nude mice. Several studies showed that mtDNA mutations suppress apoptosis in cultured cybrids (32, 33) , which is in accordance to the crucial role played by mitochondria and the respiratory chain in apoptosis (34) .
WT and tRNAmut cybrids showed marked differences concerning motility and migration: tRNAmut cybrids displayed higher individual cell motility (when plated in low density) and migration (wound healing) than WT cybrids. These differences were associated with distinct cell morphology: WT cybrids formed colonies with clear cell-cell interactions, whereas tRNAmut cybrids appeared as individualized (dispersed) cells with few cell-cell contacts. Noteworthily, when injected in nude mice, tRNAmut cybrids produced more lung metastases than WT cybrids, suggesting that the in vitro migratory capacities of tRNAmut cybrids were associated with an increased metastatic ability in vivo.
Our results fit with previous findings suggesting that OXPHOS dysfunction increases the migratory and metastatic potential of cancer cells (11, 12, 33) . In some of these studies, reactive oxygen species (ROS) were pointed out as important mediators of the enhanced migration and metastization of OXPHOS-deficient tumour cells (12) , although the underlying effector molecules remain to be clarified.
OXPHOS dysfunction has been advanced to modulate the ECM in a way that promotes cell invasion and metastatic properties (35, 36) . Crucial for migration and invasion, the crosstalk cancer cell-stroma is mediated by adhesion proteins, where integrins play a central role by regulating a diverse array of cellular functions necessary to the initiation, progression and metastization of solid tumours (18) . Surface integrin-β1 promotes cell migration and invasion by binding to fibronectin in the ECM. In our experiments, tRNAmut cybrids showed both an increased expression and binding to fibronectin compared with 143B and WT cybrids. Interestingly, while no significant changes were observed in the total levels of integrin-β1, tRNAmut cybrids consistently exhibited higher levels of the 130 kDa integrin-β1 isoform than 143B and WT cells.
Integrins are glycoproteins and therefore major carriers of N-glycans (sequences of carbohydrates attached to asparagine residues of the protein). Glycosylation has been described as a fundamental molecular mechanism affecting the folding, expression, intracellular trafficking, localization, activity and half-life of several proteins, both in normal and pathological conditions (37, 38) . Integrin-β1 is tightly regulated by N-glycosylation. Indeed, deglycosylation mutants of integrin-β1, or treatment with the N-glycosylation inhibitor tunicamycin, abolish integrin-β1 transport to the cell surface and its binding to ECM substrates (21) . Moreover, aberrant N-glycosylation with increased expression of β-1,6 GlcNAc branched N-glycans (catalysed by GnTV enzyme) directs more integrin-β1 delivery to plasma membrane and promotes fibronectin-based cell migration and invasion (39) . Such β-1,6 GlcNAc branched glycans in integrin-α5β1 have been shown to be associated with increased cell spreading on fibronectin in a context of oncogenic signalling driven by mutant Ras (40) .
Our results show that integrin-β1 N-glycosylation pattern differs between WT and tRNAmut cybrids, specifically in the levels of integrin-β1 modified with the β-1,6 GlcNAc branched N-glycans that were significantly elevated in tRNAmut cybrids. In line with previous reports (39, 40) , such integrin-β1 N-glycan modification in tRNAmut cybrids may account for their increased binding to fibronectin, as well as for enhanced motility and migration capabilities.
Our observation of differential integrin-β1 N-glycosylation levels between tRNAmut and WT cybrids may be associated with (i) increased expression or enzymatic activity of GnT-V or (ii) increased availability of the substrates for N-glycosylation such as UDP-N-acetylglucosamine (UDP-GlcNAc), promoting an increased N-glycosylation biosynthetic pathway. The production of UDP-GlcNAc for N-glycosylation is achieved by the hexosamine biosynthetic pathway, which requires the coordination of both glucose and glutamine metabolism. Indeed, UDP-GlcNAc levels have been shown to be critical factors in the production of β-1,6-branched N-glycans, as they increase the production of these sugar chains without an increase in GnT-V activity (41) . While our data associate OXPHOS deficiency to increased glucose uptake, it has also been observed that glutamine metabolism is essential for cancer cells harbouring mtDNA mutations (42) . Taking all this together, we speculate that OXPHOS deficiency may remodel glucose and glutamine metabolism, thereby affecting the intracellular pool of N-glycosylation substrates and leading to the modification of the N-linked glycosylation of membrane proteins like integrin-β1. Interestingly, Wellen et al. (43) demonstrated that glucose availability to the hexosamine pathway regulates interleukin-3 receptor alpha (IL-3Rα) surface expression in a N-linked glycosylation-dependent manner. Our finding on the association between carbohydrate maturation on integrin-β1 and the glycolytic shift caused by OXPHOS deficiency thus support and extend the results of Wellen et al. (43) , strengthening the notion that cellular metabolism can affect signal transduction through regulation of glycosylation.
Hung et al. (44) had advanced a connection between OXPHOS deficiency and integrin signalling in a model of gastric cancer cells. Hung et al. (44) used a model of chemically induced OXPHOS dysfunction (using the mitochondrial inhibitors oligomycin and antimycin A) and proposed that mitochondrial dysfunction enhances migration through mitochondria-generated ROSmediated integrin-β5 expression. We focussed mainly on the effects elicited by genetically induced OXPHOS dysfunction, but we also observed that treatment with the mitochondrial complex I inhibitor phenformin resulted in increased surface expression of integrin-β1. Our results, combined with those of Hung et al. (44) , suggest that mitochondrial dysfunction is associated with integrin-mediated cell motility, migration and invasion.
In conclusion, we have built an in vitro cybrid cell model that recapitulates OXPHOS dysfunction of tumour cells induced by mtDNA mutations. In this study, we show that OXPHOS dysfunction has a major impact in the migratory phenotype of cancer cells in vitro, and that the adhesion glycoprotein integrin-β1 may be behind the mechanism by which the defect in OXPHOS leads to an increased motility and migration capacity. In addition, when transplanted in nude mice, tRNAmut cybrids display increased tumourigenic/metastatic potential than WT cybrids.
Materials and Methods
Cell lines
Cell lines were cultured in Dulbecco's modified Eagle's medium high-glucose supplemented with 10% (v/v) inactivated foetal bovine serum (FBS), 100 units/ml penicillin, 100 µg/ml streptomycin (all from GIBCO, Life Technologies, NY, USA) and 50 µg/ml uridine (Sigma-Aldrich, St. Louis, USA). Cells were maintained at 37°C, 5% CO 2 in a humidified incubator and cultured as a monolayer.
The 143Bρ0 is an mtDNA-depleted cell line, derived from 143B osteosarcoma cells after transient expression of UL12.5 Herpes simplex protein (45) . Compared with the alternative method of generating ρ0 cells-long-term exposure to ethidium bromidethis method of mtDNA depletion has the advantage of selective degradation, assuring that no alterations are induced in the nuclear DNA.
Cybrid cell lines were obtained after fusion of 143Bρ0 cells with human platelets harbouring either WT or mutant mtDNA. Platelets were isolated from peripheral blood collected in ethylenediaminetetraacetic acid (EDTA) tubes. Whole blood was mixed with one-tenth (v/v) of a 10× warm salt solution of citrate (0.15  NaCl and 0.1  trisodium citrate dehydrated, pH 7.0), and centrifuged for 20 min at 200g. To pellet the platelets, the top three-fourths of the platelet-rich plasma (supernatant) were centrifuged for 20 min at 1500g. Platelets were resuspended in physiological saline (0.15  NaCl, 15 m Tris-HCl, pH 7.4) as previously described (46) .
After isolation, the platelet suspension was centrifuged for 15 min at 1500g and the supernatant discharged. One million 143Bρ0 cells were carefully added to the platelets' pellet, which was then centrifuged for 10 min at 180g. The cellular fusion was achieved when the pellet was resuspended in 0.1 ml of PEG 45% (v/v) and incubated for 1 min. The fusion mixture was then plated in Petri dishes in different dilutions (1 : 1, 1 : 10 and 1 : 100) and selection began 48 h later, by removing uridine from the culture medium. Only the clones that survive and proliferate after uridine removal were selected.
Western blot analysis
Cells were detached with Versene dissociation solution (GIBCO) and lysed in RIPA buffer (50 m Tris-HCl, 1% NP-40, 15 m NaCl and 2 m EDTA, pH 7.5) supplemented with protease (Roche Applied Science, Penzberg, Germany) and phosphatase inhibitors (Sigma-Aldrich). Protein extracts (25-100 μg) were denatured, resolved in SDS-PAGE gels and then electrotransferred onto a nitrocellulose membrane (GE Healthcare, Piscataway, USA) for 2 h at 100 V and 4°C, or alternatively overnight at 30 V and 4°C.
Membranes were blocked for 1 h at room temperature [in phosphate buffered saline (PBS) containing 0.5% Tween-20 and 5% low-fat dry milk] and incubated with primary antibodies diluted in blocking solution, according to the manufacturer's instructions. The primary antibodies used were the following: α-tubulin (Sigma-Aldrich); COXII (Mitosciences, Abcam, Cambridge, UK); SDHA (Mitosciences); fibronectin (Santa Cruz, Dallas, USA); integrin-β1 (BD Transduction Laboratories, San Jose, USA). Membranes were then washed with PBS-T and incubated with the suitable horseradish peroxidase conjugated secondary antibody. Protein bands were detected by chemiluminescense and X-ray film exposure (GE Healthcare).
Measurement of oxygen consumption
Cells were trypsinized and resuspended in FBS-containing culture medium. Cells were counted and aliquots containing 5 × 10 6 cells were further pelleted, resuspended in Krebs buffer containing 132 m NaCl, 4 m KCl, 1 m CaCl 2 , 1.2 m NaH 2 PO 4 , 1.4 m MgCl 2 , 6 m glucose and 10 m 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and allowed to equilibrate for 5 min in an oxygen electrode chamber (DW1, Clark electrode, Hansatech, Norfolk, UK), after calibration for dissolved oxygen. After recording the basal rate of oxygen consumption (in nmol/ml/min), maximum respiration was assessed by adding 2.5 μ CCCP plus 2 μg/ml oligomycin to the reaction medium. Potassium cyanide (700 μ) was added at the end of the experiment to confirm O 2 consumption by mitochondria.
Glucose and lactate quantification
Identical cell numbers (10 4 ) were plated in 6-well plates and the medium was collected at 0 h and after 96 h in culture. Glucose levels present in the conditioned medium after 96 h in culture were quantified using the Glucose GOD/PAP Kit (Roche Applied Science) and subtracted to the initial levels (0 h). Lactate was quantified in a similar manner, using the lactic oxidase-peroxidase (LO-POD) enzymatic colorimetric assay (Spinreact, Sant Esteve de Bas, Spain).
Cell population growth and apoptosis
For cell population growth studies, identical cell numbers (10 4 ) were plated in 6-well plates and cells were counted in 24 h intervals, for 96 h, using a Z Series Particle Count and Size Analyser (Beckman Coulter, Brea, USA). The terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay ['In situ cell death detection kit, fluorescein' (Roche Applied Science)] was used to evaluate and quantify apoptosis induced by STS. Cells were treated for 4 h with three concentrations-25, 50 and 100 n-of STS in dimethyl sulfoxide and the assay was performed according to the manufacturer's protocol. The fluorescence was detected in the range of 515-565 nm by flow cytometry (Beckman Coulter). Analysis of the results was performed in FlowJo software (Tree Star) and the geometric mean of the curves was calculated. Whenever necessary, a gate was drawn to exclude unspecific fluorescence.
Motility and migration
For individual motility assays, cells were plated in low density (10 4 cells) in a 12-well plate. After seeding for 24 h, cells were monitored for 14 h using a Leica DMI 6000B time-lapse microscope (Leica Microsystems, Wetzlar, Germany). The movement covered by a single cell was quantified only if the cell was clearly individualized, remained in the field and did not enter division or apoptosis. For migration (wound healing) assays, cells were plated in high density (5 × 10 5 cells), to reach confluence. After seeding for 8 h, the cell monolayer was scratched with a pipette tip, cell debris was removed by replacing the culture medium and cells were monitored in a Leica DMI 6000B time-lapse microscope (Leica Microsystems) using the 10× objective. Migration was defined as the capacity to migrate into the wound and measured as the percentage of wound coverage through time. For both assays, images were automatically collected in each field every 5 min using LAS AF software (Leica Microsystems) and further processed using the same software. Appropriate groups of images corresponding to the same field were joined to make the film.
PNGase F and Endo H digestion
Total cell lysates (30 µg) were combined with denaturing buffer and incubated at 100°C for 10 min. Samples were then digested with 1 unit of PNGase F or Endo H (New England Biolabs, Ipswich, USA) overnight at 37°C. The deglycosylated proteins were loaded in SDS-PAGE gels and immunoblotted with anti-integrin-β1 antibody (BD Transduction Laboratories). For controls, samples were incubated without the enzymes.
Integrin-β1 immunoprecipitation and lectin blot analysis
Equal amounts of total protein (1500 µg) from each cell lysate were pre-cleared with protein G-sepharose beads (GE Healthcare) for 1 h and the supernatant was incubated overnight with 5 µg of monoclonal antibody against integrin-β1 (BD Transduction Laboratories). After that, incubation with protein G-sepharose for 2 h was performed and the immune complexes were released by boiling for 5 min at 95°C in Laemmli buffer. Protein extracts were resolved in SDS-PAGE gels, electrotransferred onto a nitrocellulose membrane (GE Healthcare) for 2 h at 100 V and then probed with the primary antibody against integrin-β1 (BD Transduction Laboratories). For β-1,6 GlcNAc branched structure analysis on integrin-β1 immuno-precipitated, membranes were probed with biotinylated Phaseolus vulgaris leucoagglutinin lectin (L-PHA), a lectin that specifically recognizes the β-1,6 GlcNAc branched N-glycan structure catalysed by N-acetylglucosaminyltransferase V (Vector Laboratories, Burlingame, USA). Protein bands were detected by chemiluminescense and X-ray film exposure (GE Healthcare).
Confocal microscopy
Cells were seeded on top of glass coverslips, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with 5% bovine serum albumin (BSA) and incubated 1 h at room temperature with integrin-β1 antibody (Abcam). Alexa fluor 488 (Invitrogen, Life Technologies, NY, USA) was used as secondary antibody. Images were acquired on a Leica TCS SP5II confocal microscope (Leica Microsystems) using a Plan-Apochromat 63× oil objective. Images were processed using the LAS AF software (Leica Microsystems). Background noise was minimal when optimal gain/offset settings for the detectors were used. Digital images were optimized for contrast and brightness using Adobe Photoshop (Adobe Systems, San Jose, USA).
Adhesion assay
Cell adhesion assay was performed in 96-well plates, previously coated with fibronectin, type-I or type-IV collagen (all from Sigma-Aldrich) (5 µg/ml) overnight at 4°C. Plates were washed three times in PBS and non-specific-binding sites were blocked by adding 0.5% BSA (w/v) in PBS containing Pen/Strep for 2 h at 37°C. A total volume of 100 µl serum-free medium, containing 10 6 cells/ml, was plated in coated wells for 30 min, after which plates were washed with PBS to remove non-adherent cells, and the attached cells were fixed with acetone : methanol (1 : 1) for 10 min at 4°C. Cell adhesion was determined following the colorimetric method described by Busk et al. (47) . The absorbance was measured at 570 nm with a microplate reader. The attachment of cells to wells coated with 1 mg/ml of poly--Lys and fixed with 4% paraformaldehyde before aspiration was defined as 100% of adhesion.
Imaging flow cytometry
To characterize the integrin-β1 and integrin-α5β1 distribution by imaging flow cytometry, 10 6 cells were seeded for 24 h, detached with Versene (GIBCO) and processed as live cells in suspension. Cells were incubated with integrin-β1 (Abcam) and integrin-α5β1 (Merck Millipore, Billerica, USA) antibodies for 1 h at room temperature. Alexa fluor 488 (Invitrogen) was used as the secondary antibody. Samples were analysed in the imaging flow cytometer (ImageStream ® , Amnis, EDM Millipore), using a 488 nm excitation laser. All images were captured with the 40× objective (image pixel 0.5 μm 2 ) using the INSPIRE software (Amnis, EDM Millipore), acquiring at least 10 000 events. Data were analysed using the IDEAS ® software (Amnis, EDM Millipore, version 6.0.348) using only the single cell events. For the quantification of the fluorescence intensity of the labelled integrin-β1/integrin-α5β1 in the plasma membrane, a mask fitting the plasma membrane was built using the corresponding bright-field image, and fluorescence intensity was quantified within this region of interest.
Phenformin treatments
The effect of phenformin (Sigma-Aldrich) over respiration was evaluated by adding 5 m phenformin before CCCP or oligomycin in oxygen consumption experiments described above. For confocal microscopy or imaging flow cytometry, 5 m phenformin was added 1 h before fixation or cell harvesting, respectively.
Xenografts
All the procedures were carried out in accordance with the Guidelines for the Care and Use of Laboratory Animals, directive 86/609/ EEC. N:NIH(s)II:nu/nu nude mice were subcutaneously injected in the dorsal flanks with 10 6 cells of WT or tRNAmut cybrids.
Mouse weight and tumour width and length were measured with callipers every week. Excised tumours and lungs (to assess the presence of metastases) were fixed with 4% neutral buffered formalin and paraffin-embedded. The presence of lung metastases was evaluated by immunohistochemistry using anti-vimentin monoclonal antibody (DAKO, Glostrup, USA), and the streptavidin-biotin-horseradish peroxidase technique.
Statistical analysis
Statistical analysis was performed using GraphPad software (GraphPad Software Inc., La Jolla, USA), using Student's t-test or two-way ANOVA with Tukey post hoc test. Differences were considered statistically significant when P < 0.05 (*P < 0.05; **P < 0.01; ***P < 0.001).
